Daniel Dragomire, MD
Nephrology · East Providence, RINPI 1134192206
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Akebia Therapeutics Inc at 43.8% of the total. 2025 is the largest year on record at $147, more than ten times the $3 reported in 2023. That places this record below the midpoint for nephrology clinicians in RI, where the typical reported total is $491.
Across 6 payments — averaging $46.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Akebia Therapeutics Inc$122
- Baxter Healthcare$108
- Amgen$26
- Travere Therapeutics, Inc.$22
What the payments were for
- Food & beverage$25692%
- Education$228%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Akebia Therapeutics Inc | 1 | $122 |
| Baxter Healthcare | 1 | $108 |
| Amgen | 1 | $26 |
| Travere Therapeutics, Inc. | 3 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vafseo$122
How this compares
$278 in reported general payments places this provider in the 40th percentile of 45 nephrology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 65 | $38,113 |
| JardianceEmpagliflozin | 52 | $36,714 |
| InpefaSotagliflozin | 16 | $9,188 |
| Sevelamer Carbonate | 32 | $7,370 |
| Calcium Acetate | 68 | $6,130 |
| ClinolipidFat Emulsion/Olive/Soy/Phospho | 39 | $5,938 |
| Amlodipine Besylate | 203 | $1,481 |
| Tacrolimus | 12 | $1,223 |
| Torsemide | 68 | $1,210 |
| Bumetanide | 63 | $1,204 |
| Carvedilol | 61 | $881 |
| Hydralazine Hcl | 30 | $801 |
| Losartan Potassium | 93 | $762 |
| Minoxidil | 13 | $588 |
| Lisinopril | 85 | $560 |
Paid to pharmacies, not to this prescriber.
Other nephrology in East Providence
- Larissa Kruger GomesEast Providence$4K
- Manini VishwanathEast Providence$436
- Prerna GanjooEast Providence$309
- Michael ThursbyEast Providence$249
- Christopher CosgroveEast Providence$136
- George LeeEast Providence$95
- Perola LambaEast Providence$48
- Mordecai StolkEast Providence$29
- Charles McCoyEast Providence$28
- Michael MonsourEast Providence$4
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.